Desh Rakshak Aushdhalaya Limited , a manufacturer of Ayurvedic and herbal products, has successfully completed a preferential allotment of equity shares to non-promoter category investors. The company, established in 1901 and based in Haridwar, Uttarakhand, made this announcement in compliance with regulatory requirements.

Key Details of the Preferential Issue

Regulatory Compliance and Approval Process

The Board of Directors of Desh Rakshak Aushdhalaya Limited approved the allotment in a meeting held on September 9, 2025. This decision followed shareholder approval and was conducted in accordance with:

• The Companies Act, 2013
• Securities and Exchange Board of India (SEBI) regulations
• SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018

Next Steps

The company has initiated corporate actions with the National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) to obtain trading approval for the newly issued shares. This step is crucial for integrating the new shares into the market trading system.

Company Background

Desh Rakshak Aushdhalaya Limited, with its Corporate Identification Number (CIN) L33119UR1981PLC006092, operates from Bhagwant Kuti, Kankhal, Haridwar. The company specializes in the manufacture of Ayurvedic and herbal products, continuing a tradition that spans over a century since its establishment in 1901.

This preferential issue represents a significant corporate action for Desh Rakshak Aushdhalaya, potentially impacting its capital structure and providing additional funds for its operations in the Ayurvedic and herbal products sector.

Desh Rakshak Aushdhalaya Limited , a manufacturer of Ayurvedic and herbal products, has received a significant boost in its capital structure. The company recently obtained listing approval from BSE Limited for 12,60,000 equity shares issued on a preferential basis to non-promoters.

Key Details of the Preferential Issue

Next Steps and Compliance

The company is now required to take the following actions:

1. Apply for trading approval within seven working days from the date of listing approval.
2. Submit necessary documents to BSE, including:
   • Confirmation letters from NSDL/CDSL about crediting shares to beneficiary accounts
   • Confirmation of lock-in for pre-preferential holding (if applicable)

Regulatory Framework

This preferential issue is governed by:

• SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018
• SEBI Master Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024
• SEBI Circular no. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023

Impact on the Company

The successful listing approval marks a significant milestone for Desh Rakshak Aushdhalaya Limited. This preferential issue is expected to strengthen the company's capital base, potentially providing additional resources for business expansion or other corporate purposes.

Market Implications

Investors and market participants should note that:

• The new shares will be subject to regulatory lock-in periods as per SEBI guidelines.
• The company's shareholding pattern may see changes, with potential implications for stock liquidity and market dynamics.

As Desh Rakshak Aushdhalaya Limited progresses through the final stages of this preferential issue, market observers will be keen to see how the company utilizes this capital infusion to drive growth in the Ayurvedic and herbal products sector.